CB
NVO

Cadence Bank’s Novo Nordisk NVO Stock Holding History

Cadence Bank’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,892
Closed -$270K – 337
2024
Q2 		$270K Sell
1,892
-676
-26% -$89.6K 0.02% 256
2024
Q1 		$330K Hold
2,568
– – 0.02% 266
2023
Q4 		$266K Sell
2,568
-614
-19% -$60.7K 0.02% 289
2023
Q3 		$289K Hold
3,182
– – 0.03% 275
2023
Q2 		$257K Hold
3,182
– – 0.02% 296
2023
Q1 		$253K Buy
+3,182
New +$226K 0.02% 293

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cadence Bank's NVO Position: Q3 2024 in Review

Cadence Bank sold out of Novo Nordisk (NVO) in Q3 2024, closing a stake of 1,892 shares — an estimated $270K sold.

Cadence Bank first reported a position in NVO in Q1 2023 and held it in 6 quarters. The position peaked at $330K in Q1 2024. 1,784 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • Cadence Bank reported no remaining Novo Nordisk position as of Q3 2024 after selling out during the quarter.
  • Cadence Bank sold 1,892 Novo Nordisk shares in Q3 2024, an estimated $270K.
  • Cadence Bank first reported a position in Novo Nordisk in Q1 2023 and held it in 6 quarters.
  • Cadence Bank's Novo Nordisk position peaked at $330K in Q1 2024.
  • 1,784 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on Cadence Bank's 13F filing for Q3 2024, filed 13 Nov 2024.